Peng Chen

2.5k total citations
113 papers, 1.2k citations indexed

About

Peng Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Peng Chen has authored 113 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Peng Chen's work include Cancer Immunotherapy and Biomarkers (19 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (13 papers). Peng Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (13 papers). Peng Chen collaborates with scholars based in China, United States and Malaysia. Peng Chen's co-authors include Shenghong Zhang, Shu Xu, Minhu Chen, Lihui Lin, Wenjie Liu, Qiang Zhao, Hua Guo, Daowei Wang, Cai‐Xia Zhang and Long Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peng Chen

104 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Chen China	17	467	448	405	259	148	113	1.2k
Wiesława Niklińska Poland	23	393 0.8×	577 1.3×	333 0.8×	271 1.0×	137 0.9×	77	1.3k
Yi Gao China	22	273 0.6×	690 1.5×	324 0.8×	266 1.0×	182 1.2×	87	1.4k
Yinghao Sun China	16	611 1.3×	556 1.2×	484 1.2×	178 0.7×	93 0.6×	30	1.4k
Toshimitsu Yamaoka Japan	21	645 1.4×	529 1.2×	525 1.3×	178 0.7×	108 0.7×	51	1.4k
Zhen Liu China	20	407 0.9×	661 1.5×	327 0.8×	295 1.1×	250 1.7×	86	1.5k
Haoran Li China	14	336 0.7×	491 1.1×	187 0.5×	345 1.3×	169 1.1×	81	1.1k
Deqiang Wang China	18	325 0.7×	506 1.1×	320 0.8×	374 1.4×	116 0.8×	94	1.1k
Tatsuya Nagano Japan	22	726 1.6×	702 1.6×	772 1.9×	279 1.1×	172 1.2×	116	2.0k
Xi Yu China	23	265 0.6×	547 1.2×	202 0.5×	243 0.9×	155 1.0×	64	1.4k

Countries citing papers authored by Peng Chen

Since Specialization

Citations

This map shows the geographic impact of Peng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Chen more than expected).

Fields of papers citing papers by Peng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Chen. The network helps show where Peng Chen may publish in the future.

Co-authorship network of co-authors of Peng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Chen. A scholar is included among the top collaborators of Peng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Chen. Peng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Kexin, Na‐Na Tao, Sheng‐Tao Cheng, et al.. (2024). ZNF148 inhibits HBV replication by downregulating RXRα transcription. Virology Journal. 21(1). 35–35. 2 indexed citations

Yuan, Shuai, et al.. (2024). Relationship between circulating miRNA-222-3p and miRNA-136-5p and the efficacy of docetaxel chemotherapy in metastatic castration-resistant prostate cancer patients. BMC Urology. 24(1). 275–275. 1 indexed citations

Wang, Yuying & Peng Chen. (2024). Research Advances in Infectious Mononucleosis Caused by Epstein-Barr Virus. Open Journal of Pediatrics. 14(1). 108–121. 2 indexed citations

Zhu, Ke‐Wei, Feng Gao, Bin Huang, et al.. (2024). Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). International Journal of COPD. Volume 19. 501–518. 25 indexed citations

Chen, Peng, et al.. (2024). Establishment of a novel efferocytosis potential index predicts prognosis and immunotherapy response in cancers. Heliyon. 10(9). e30337–e30337.

Zhang, Linlin, Jinliang Chen, Zhaoting Meng, et al.. (2023). Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study. Molecular Cancer. 22(1). 124–124. 13 indexed citations

Fan, Bin, An Liu, Peng Chen, et al.. (2023). [Rapid identification of components in Wuzhuyu Decoction using UHPLC Q-Exactive Orbitrap MS~n and molecular network technology].. PubMed. 48(1). 71–81.

Yu, Dan, Peng Chen, Xueyan Zhang, et al.. (2023). Association of lymphopenia and RDW elevation with risk of mortality in acute aortic dissection. PLoS ONE. 18(3). e0283008–e0283008. 5 indexed citations

Zhu, Ke‐Wei, Peng Chen, Ying Bi, et al.. (2023). Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study. Advances in Therapy. 41(1). 391–412. 4 indexed citations

10.

Wu, Mao, et al.. (2023). Glutathione-S-Transferase p 1 Gene Promoter Methylation in Cell-Free DNA as a Diagnostic and Prognostic Tool for Prostate Cancer: A Systematic Review and Meta-Analysis. International Journal of Endocrinology. 2023. 1–9. 11 indexed citations

11.

Chen, Peng, et al.. (2023). Supramolecular nanofibers co-loaded with dabrafenib and doxorubicin for targeted and synergistic therapy of differentiated thyroid carcinoma. Theranostics. 13(7). 2140–2153. 13 indexed citations

12.

Xu, Lulu, et al.. (2023). Risk factors for severe low anterior resection syndrome in patients with rectal cancer undergoing sphincter‑preserving resection: A systematic review and meta‑analysis. Oncology Letters. 27(1). 30–30. 5 indexed citations

13.

Liu, Wenjie, et al.. (2023). Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis. BMC Cancer. 23(1). 143–143. 14 indexed citations

14.

Liu, Wenjie, et al.. (2023). First-line tremelimumab plus durvalumab and chemotherapy versus chemotherapy alone for metastatic non-small cell lung cancer: a cost-effectiveness analysis in the United States. Frontiers in Pharmacology. 14. 1163381–1163381. 3 indexed citations

15.

He, Wenhua, Peng Chen, Yupeng Lei, et al.. (2022). Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis. Critical Care. 26(1). 52–52. 15 indexed citations

16.

Duan, Yuansheng, et al.. (2022). Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma. Frontiers in Endocrinology. 13. 914946–914946. 6 indexed citations

17.

Wang, Daowei, Jie Yan, Jun Xiao, et al.. (2021). Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma. Clinical Cancer Research. 28(4). 793–809. 93 indexed citations

18.

Chen, Peng, et al.. (2020). The study of internal mammary lymph node dissection guided by modified radiotracer injection technique in breast cancer-a case report and review. Gland Surgery. 9(2). 430–436. 2 indexed citations

19.

Chen, Peng, et al.. (2020). Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer. Cancer Cell International. 20(1). 316–316. 6 indexed citations

20.

Zhang, Yuquan, Peng Chen, Gang Wu, et al.. (2011). Expression of NLK and Its Potential Effect in Ovarian Cancer Chemotherapy. International Journal of Gynecological Cancer. 21(8). 1380–1387. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact